Full Name
BUYSE, Marc
Email
marc.buyse@uhasselt.be
 
Loading... 5 0 5 0 false
Loading... 6 0 5 0 false

Publications

Refined By:
Date Issued:  [2010 TO 2019]
Internal UHasselt:  BURZYKOWSKI, Tomasz

Results 1-20 of 35 (Search time: 0.01 seconds).

Issue DateTitleContributor(s)TypeCat.
12019Disease-free survival as a surrogate for overall survival in patients with HER2-positive, early breast cancer in trials of adjuvant trastuzumab for up to 1 year: a systematic review and meta-analysisSaad, Everardo D.; Squifflet, Pierre; BURZYKOWSKI, Tomasz; Quinaux, Emmanuel; Delaloge, Suzette; Mavroudis, Dimitris; Perez, Edith; Piccart-Gebhart, Martine; Schneider, Bryan P.; Slamon, Dennis; Wolmark, Norman; BUYSE, MarcJournal ContributionA1
22019Detection of atypical data in multicenter clinical trials using unsupervised statistical monitoringTrotta, Laura; Kabeya, Yuusuke; BUYSE, Marc; Doffagne, Erik; Venet, David; Desmet, Lieven; BURZYKOWSKI, Tomasz; Tsuburaya, Akira; Yoshida, Kazuhiro; Miyashita, Yumi; Morita, Satoshi; Sakamoto, Junichi; Praveen, Paurush; Oba, KojiJournal ContributionA1
32019A Poisson approach to the validation of failure time surrogate endpoints in individual patient data meta-analysesRotolo, Federico; PAOLETTI, Xavier; BURZYKOWSKI, Tomasz; BUYSE, Marc; Michiels, StefanJournal ContributionA1
42019Evaluation of Continuous Tumor-Size-Based End Points as Surrogates for Overall Survival in Randomized Clinical Trials in Metastatic Colorectal CancerBURZYKOWSKI, Tomasz; Coart, E.; Saad, E.D.; Shi, Q.; Sommeijer, D.W.; Bokemeyer, C.; Díaz-Rubio, E.; Douillard, Jean-Yves; Falcone, A.; Fuchs, C.; Goldberg, R.M.; Hecht, R.; Hoff, P.M.; Hurwitz, H.; Kabbinavar, F.F.; Koopman, M.; Maughan, T.; Punt, C.J.A.; Saltz, L.; Schmoll, Hans-Joachim; Seymour, M.T.; Tebbutt, N.C.; Tournigand, C.; Van Cutsem, E.; de Gramont, A.; Zalcberg, J.R.; BUYSE, MarcJournal ContributionA1
52019Chronological Trends in Progression-Free, Overall, and Post-Progression Survival in First-Line Therapy for Advanced NSCLCRutkowski, Jacek; Saad, Everardo D.; BURZYKOWSKI, Tomasz; BUYSE, Marc; Jassem, JacekJournal ContributionA1
62018The search for surrogate endpoints for immunotherapy trialsBUYSE, Marc; BURZYKOWSKI, Tomasz; Saad, Everardo D.Journal ContributionA2
72018Understanding and Communicating Measures of Treatment Effect on Survival: Can We Do Better?Saad, Everardo D.; Zalcberg, John R.; Peron, Julien; Coart, Elisabeth; BURZYKOWSKI, Tomasz; BUYSE, MarcJournal ContributionA1
82018Statistical evaluation of surrogate endpoints in cancer clinical trialsBUYSE, Marc; MOLENBERGHS, Geert; PAOLETTI, Xavier; Oba, K.; ALONSO ABAD, Ariel; VAN DER ELST, Wim; BURZYKOWSKI, TomaszBook SectionB2
92017Applied Surrogate Endpoint Evaluation Methods with SAS and RALONSO ABAD, Ariel; BIGIRUMURAME, Theophile; BURZYKOWSKI, Tomasz; BUYSE, Marc; MOLENBERGHS, Geert; MUCHENE, Leacky; PERUALILA, Nolen Joy; SHKEDY, Ziv; VAN DER ELST, WimBookB1
102017Evaluation of failure time surrogate endpoints in individual patient data meta-analyses of randomized clinical trials. A poisson approachRotolo, Federico; PAOLETTI, Xavier; BURZYKOWSKI, Tomasz; BUYSE, Marc; Michiels, StefanJournal ContributionM
112017Adoption of Pathologic Complete Response as a Surrogate End Point in Neoadjuvant Trials in HER2-Positive Breast Cancer Still an Open QuestionBURZYKOWSKI, Tomasz; Saad, Everardo D.; BUYSE, MarcJournal ContributionA1
122017Precision medicine needs randomized clinical trialsSaad, Everardo D.; PAOLETTI, Xavier; BURZYKOWSKI, Tomasz; BUYSE, MarcJournal ContributionA1
132017Use of the Beta-Binomial Model for Central Statistical Monitoring of Multicenter Clinical TrialsDesmet, Lieven; Venet, David; Doffagne, Erik; Timmermans, Catherine; LEGRAND, Catherine; BURZYKOWSKI, Tomasz; BUYSE, MarcJournal ContributionA1
142016Statistical monitoring of data quality and consistency in the Stomach Cancer Adjuvant Multi-institutional Trial Group TrialTimmermans, Catherine; Doffagne, Erik; Venet, David; Desmet, Lieven; LEGRAND, Catherine; BURZYKOWSKI, Tomasz; BUYSE, MarcJournal ContributionA1
152016Statistical evaluation of surrogate endpoints with examples from cancer clinical trialsBUYSE, Marc; MOLENBERGHS, Geert; PAOLETTI, Xavier; Oba, Koji; ALONSO ABAD, Ariel; VAN DER ELST, Wim; BURZYKOWSKI, TomaszJournal ContributionA1
162016Neoadjuvant as Future for Drug Development in Breast Cancer-LetterBUYSE, Marc; BURZYKOWSKI, Tomasz; Saad, Everardo D.Journal ContributionA1
172016Adaptive Randomization of Neratinib in Early Breast CancerBUYSE, Marc; Saad, E.; BURZYKOWSKI, TomaszJournal ContributionA1
182016An Information-Theoretic Approach for the Evaluation of Surrogate Endpoints Based on Causal InferenceALONSO ABAD, Ariel; VAN DER ELST, Wim; MOLENBERGHS, Geert; BUYSE, Marc; BURZYKOWSKI, TomaszJournal ContributionA1
192015Event-Free Survival Is a Surrogate for Overall Survival in Patients Treated for Acute Myeloid LeukemiaSchlenk, Richard F.; Doehner, Hartmut; Doehner, Konstanze; Ganser, Arnold; Heuser, Michael; Benner, Axel; BUYSE, Marc; BURZYKOWSKI, TomaszJournal ContributionM
202015On the relationship between the causal-inference and meta-analytic paradigms for the validation of surrogate endpointsALONSO ABAD, Ariel; VAN DER ELST, Wim; MOLENBERGHS, Geert; BURZYKOWSKI, Tomasz; BUYSE, MarcJournal ContributionA1